Stability and Formulation of Erlotinib in Skin Creams

Stability and Formulation of Erlotinib in Skin Creams

Recent studies have highlighted the benefit of repurposing oral erlotinib (ERL) treatment in some rare skin diseases such as Olmsted syndrome. The use of a topical ERL skin treatment instead of the currently available ERL tablets may be appealing to treat skin disorders while reducing adverse system...

Full description

Bibliographic Details
Main Authors: David Nguyen, Philippe-Henri Secrétan, Camille Cotteret, Emmanuelle Jacques-Gustave, Céline Greco, Christine Bodemer, Joel Schlatter, Salvatore Cisternino
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Molecules
Subjects:
dermatology
drug repurposing
erlotinib
rare disease
stability indicating
Olmsted
Online Access:https://www.mdpi.com/1420-3049/27/3/1070

Internet

https://www.mdpi.com/1420-3049/27/3/1070

Similar Items